Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

LabStyle Innovations Appoints Renowned Diabetes Expert to Its Board of Directors

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
Appointment of Dr. Itamar Raz of Hadassah Medical Center strengthens board’s medical and research expertise.

Dr. Raz expands the size of LabStyle’s board to seven directors, and he will serve on the Compensation Committee of the board. He will continue to lead LabStyle’s Scientific Advisory Committee. LabStyle made this announcement from the American Diabetes Association’s 73rd Scientific Sessions, which is underway at the McCormick Place Convention Center in Chicago.

Dr. Raz is a world-renowned leader in diabetes treatment and research, and is an advisor to leading companies in the field. He currently serves as a professor of internal medicine at Hadassah University Medical Center in Israel and is head of the Diabetes Unit and Research Center at Hadassah. He is also the head of the Israel National Council of Diabetes of the Israel Ministry of Health, which is responsible for formulating national policies, the President of D-Cure, a diabetes not-for-profit organization, and the head of the Israel Diabetes Research Group.

“Dr. Raz strengthens our Board of Directors with his deep expertise in diabetes as a researcher, professor and tireless advocate for better treatment,” said Dr. Oren Fuerst, LabStyle’s Chairman and Chief Executive Officer. “He is highly visible and well regarded in the diabetes community worldwide, and will be a valuable asset to our company as we seek to bring the many benefits of Dario to diabetics around the world.”

Commenting on his appointment, Dr. Raz said, “New tools and treatments for diabetics will help to contain the devastating impact of the growing diabetes epidemic. Information is the first step in improving outcomes. Dario is an innovative device and data-management system that I believe will catalyze more frequent testing due to its all-in-one design, while its many features, including the ability to share data in real-time with caregivers, will enable personalized care. In addition web-based social interactions between patients catalyzed by Dario create the potential for significant benefits through greater patient compliance.”

At Hadassah Hebrew University Hospital, Dr. Raz is currently leading several international clinical studies involving prevention and treatment of type 1 diabetes. Dr. Raz has published extensively on diabetes with more than 190 publications to his credit, and he also serves as a member of several medical editorial boards. Dr. Raz has organized several international meetings on diabetes, the largest being CODHy – Controversies in Obesity, Diabetes and Hypertension.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
Genetic Signature Linked to Cancer Prognosis Identified
The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
NIH Commits $6.7 M to Advance DNA, RNA Sequencing Technology
"Can you believe they make DNA sequencers the size of staplers?" asked Meni Wanunu, Ph.D. "Ideas that were crazy twenty years ago are now happening!"
Curcumin Shows Promise as Cancer Treatment
When delivered at the correct circadian phase, curcumin demonstrates sustained toxicity in cancer cells and should be considered for use in patient care.
"Junk" DNA Critical for Heart Function
Loss of noncoding elements of genome, known as enhancers, results in abnormalities of heart functions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos